Insight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking
- PMID: 20011149
- PMCID: PMC2770367
- DOI: 10.6026/97320630004024
Insight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking
Abstract
Pyrazinamide (PZA) - an important drug in the anti-tuberculosis therapy, activated by an enzyme Pyrazinamidase (PZase). The basis of PZA resistance in Mycobacterium tuberculosis was owing to mutation in pncA gene coding for PZase. Homology modeling of PZase was performed using software Discovery Studio (DS) 2.0 based on the crystal structure of the PZase from Pyrococcus horikoshii (PDB code 1im5), in this study. The model comprises of one sheet with six parallel strands and seven helices with the amino acids Asp8, Asp49, Trp68, Lys96, Ala134, Thr135 and Cys138 at the active site. Five mutants were generated with Gly at position 8, Thr at position 96, Arg at position 104, Tyr and Ser at position 138. The Wild-type (WT) and five mutant models were docked with PZA. The results indicate that the mutants Lys96Thr, Ser104Arg Asp8Gly and Cys138Tyr may contribute to higher level drug resistance than Cys138Ser. These models provide the first in-silico evidence for the binding interaction of PZA with PZase and form the basis for rationalization of PZA resistance in naturally occurring pncA mutant strains of M. tuberculosis.
Keywords: Mycobacterium tuberculosis; PZA resistance; PZase; docking; mutants.
Figures



Similar articles
-
Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis.Int J Mycobacteriol. 2018 Jan-Mar;7(1):16-25. doi: 10.4103/ijmy.ijmy_187_17. Int J Mycobacteriol. 2018. PMID: 29516881
-
Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis.Tuber Lung Dis. 1997;78(2):117-22. doi: 10.1016/s0962-8479(98)80004-x. Tuber Lung Dis. 1997. PMID: 9692180
-
Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China.Infect Drug Resist. 2020 Jan 22;13:217-227. doi: 10.2147/IDR.S230774. eCollection 2020. Infect Drug Resist. 2020. PMID: 32158237 Free PMC article.
-
The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.J Commun Dis. 2006 Mar;38(3):288-98. J Commun Dis. 2006. PMID: 17373362 Review.
-
The curious characteristics of pyrazinamide: a review.Int J Tuberc Lung Dis. 2003 Jan;7(1):6-21. Int J Tuberc Lung Dis. 2003. PMID: 12701830 Review.
Cited by
-
Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein.J Comput Aided Mol Des. 2013 Mar;27(3):257-76. doi: 10.1007/s10822-013-9638-6. Epub 2013 Feb 15. J Comput Aided Mol Des. 2013. PMID: 23413106
-
Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.PLoS One. 2011 Jan 24;6(1):e15785. doi: 10.1371/journal.pone.0015785. PLoS One. 2011. PMID: 21283666 Free PMC article.
-
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.World J Microbiol Biotechnol. 2014 Nov;30(11):2821-8. doi: 10.1007/s11274-014-1706-0. Epub 2014 Jul 18. World J Microbiol Biotechnol. 2014. PMID: 25034468
References
LinkOut - more resources
Full Text Sources